期刊文献+

脑恶性胶质瘤术后间质内化疗的疗效观察 被引量:5

原文传递
导出
摘要 脑胶质瘤为颅内恶性肿瘤,复发率及病死率均较高,一直是神经外科中难治性疾病之一。由于胶质瘤呈浸润性生长且与正常脑组织分界不清,手术不可能将其彻底切除,术后常有复发,单纯手术治疗平均生存期仅6个月。
出处 《中华临床医师杂志(电子版)》 CAS 2012年第6期206-206,共1页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献5

二级参考文献23

  • 1顾科,张军宁.脑胶质瘤放化疗研究进展[J].实用癌症杂志,2005,20(6):665-667. 被引量:13
  • 2白刚,罗林.脑胶质瘤的手术后化疗[J].云南医药,2006,27(4):405-408. 被引量:7
  • 3Asthagiri AR, Pouratian N, Sherman J, et al. Advances in brain tumor surgery[J]. Neurol Clin, 2007, 25(4): 975-1003.
  • 4Lukas RV, Boire A, Nicholas MK. Emergingtherapies for malignant glioma[J ]. Expert Rev Anticancer Ther, 2007, 7(12 Suppl): S29-36.
  • 5Cavaliere R, Wen PY, Schiff D. Novel therapies for malignant gliomas[J]. Neurol Clin, 2007, 25(4): 1141-71.
  • 6Balana C, Capellades J, Teixidor P, et al. Clinical course of highagrade glioma patients with a"biopsy-only"surgical approach: a need for individualised treatment [J]. Clin Transl Oncol, 2007, 9 (12): 797-803.
  • 7Verschuur AC, Grill J, Lelouch-Tubiana A, et al. Temozolomide in paediatric high-grade glioma: a key for combination therapy[J]. Br J Cancer, 2004, 91(3): 425-9.
  • 8Stupp TA, Mason WP, Van Dent MJ, et al. Radiotherapy plus concomitant and adjuvanf temolomide for glioblastoma [J ]. N Engl J Med, 2005, 325(10): 987-96.
  • 9Brandes AA, Vastola F, Basso U, et al. A prospective study on glioblastomaintheelderly[J]. Cancer, 2003, 97(3): 657-62.
  • 10Perry J, Laperriere N, Zuraw L, et al. Adjuvant chemotherapy foradults with malignant glioma: a systematic review [J]. Can Neurol Sci, 2007, 34(4): 402-10.

共引文献10

同被引文献45

  • 1薛洪利,孔令权,董宝印,梁国标,孙荣君.罂粟碱开放血脑屏障后化学治疗大脑恶性胶质瘤[J].中华神经外科杂志,1994,10(6):339-340. 被引量:7
  • 2刘沣,刘健,杨华,李玉明,向欣.脑胶质瘤经颈内动脉灌注ACNU的疗效观察[J].中国微侵袭神经外科杂志,2006,11(5):228-229. 被引量:3
  • 3Kim JW, Kim WC, Cho JH, et al.A multimodal approach including craniospinal irradiation improves the treatment outcome of high- risk intracranial nongerminomatous germ cell tumors[J]. Int J Radiat Oncol Biol Phys, 2012 Nov 1;84(3): 625-631.
  • 4Salcman M,Scholtz H,Kaplan RS ,et at. Long-term survival in patients with malignant astrocvtoma [ J ]. Nettrosurgerv .1994 .34 :213.
  • 5Callia C1, Brem S, Brem H. Local treatment of malignant brain tumors using implantable chemotherapeutic polymere [ J ]. J Natl Compr Canc Netw,2005 ,3 :721.
  • 6Cloughesy TF, Black KL, Gobin YP,et al. Intra-arterial cereport (RMP-7) and Carboplatin :a dose escalation study for recurrent malignant gliomas[ J]. Neurosurgery, 1999,44:270.
  • 7Lacroix M,Abi-said D, Fourney DR, et al. A Muleivariate analysis of 416 patients with glioblasffoma multiforme: prognosis, extent of resection, and survival[ J]. J Neurosurg,2001,95 : 190.
  • 8Abdulrauf S1, Edvardsen K, Ho KL, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of surviwd in patients with low-grade astrocytoma[ J]. J Neurosurg, 1998,88:513.
  • 9Yao Y, Kubota T, Sato K, et al. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-I in astrocytic tumours[ J ]. Acta Neurochir(Wien) ,2001,143:159.
  • 10Basser P,Mattiello J,Le Bihan D.MR diffusion tensor spectroscopy and imaging. Biophysical Journal . 1994

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部